收费全文 | 219538篇 |
免费 | 18831篇 |
国内免费 | 7650篇 |
耳鼻咽喉 | 1196篇 |
儿科学 | 3479篇 |
妇产科学 | 1703篇 |
基础医学 | 26465篇 |
口腔科学 | 3510篇 |
临床医学 | 21600篇 |
内科学 | 28709篇 |
皮肤病学 | 2946篇 |
神经病学 | 9337篇 |
特种医学 | 4148篇 |
外国民族医学 | 28篇 |
外科学 | 15623篇 |
综合类 | 32462篇 |
现状与发展 | 16篇 |
一般理论 | 28篇 |
预防医学 | 14747篇 |
眼科学 | 4905篇 |
药学 | 46213篇 |
62篇 | |
中国医学 | 11683篇 |
肿瘤学 | 17159篇 |
2024年 | 591篇 |
2023年 | 3036篇 |
2022年 | 5706篇 |
2021年 | 7817篇 |
2020年 | 7232篇 |
2019年 | 7265篇 |
2018年 | 7239篇 |
2017年 | 7490篇 |
2016年 | 7449篇 |
2015年 | 7506篇 |
2014年 | 12192篇 |
2013年 | 15969篇 |
2012年 | 11795篇 |
2011年 | 13007篇 |
2010年 | 11029篇 |
2009年 | 10465篇 |
2008年 | 10353篇 |
2007年 | 11338篇 |
2006年 | 10348篇 |
2005年 | 10087篇 |
2004年 | 8757篇 |
2003年 | 7773篇 |
2002年 | 5880篇 |
2001年 | 5786篇 |
2000年 | 4657篇 |
1999年 | 4253篇 |
1998年 | 3172篇 |
1997年 | 2831篇 |
1996年 | 2859篇 |
1995年 | 2740篇 |
1994年 | 2409篇 |
1993年 | 2106篇 |
1992年 | 1899篇 |
1991年 | 1626篇 |
1990年 | 1376篇 |
1989年 | 1270篇 |
1988年 | 1223篇 |
1987年 | 995篇 |
1986年 | 737篇 |
1985年 | 831篇 |
1984年 | 819篇 |
1983年 | 537篇 |
1982年 | 610篇 |
1981年 | 520篇 |
1980年 | 434篇 |
1979年 | 369篇 |
1978年 | 323篇 |
1977年 | 257篇 |
1976年 | 292篇 |
1975年 | 202篇 |
Background and objective
Pressure ulcer (PU) is one of the important and frequent complications of hospitalization, associated with high treatment costs. The present study was conducted to determine the incidence of PU and its direct treatment costs for patients in intensive care unit (ICU) in Iran.Material and methods
In this retrospective study, medical records of 643 discharged patients from ICU of two selected hospitals were examined. The demographic and clinical data of all patients and data of resources and services usage for patients with PU were extracted through their records. Data analysis was done using logistic regression tests in SPSS 22 software. The cost of PU treatment was calculated for each grade of ulcer.Results
The findings showed that 8.9% of patients developed PU during their stay in ICU. Muscular paralysis (OR?=?5.1), length of stay in ICU (OR?=?4.0), diabetes (OR?=?3.5) age (OR?=?2.9), smoking (OR?=?2.1) and trauma (OR?=?1.4) were the most important risk factors of PU. The average cost of PU treatment varied from USD 12 for grade I PU to USD 66?834 for grade IV PUs. The total treatment costs for all studied patients with PU was estimated at USD 519?991.Conclusion
The cost of PU treatment is significant. Since the preventive measures are more cost-effective than therapeutic measures, therefore, effective preventive interventions are recommended. 相似文献Methods: Hybrid cells containing a fragment of human chromosome 8 in scid cells (RD13B2) were used. DNA-PK activity was measured by an in vitro assay. Immunoprecipitation of the nuclear extract was performed with an anti-Ku80 antibody. Proteins co-precipitated with Ku80 were separated by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis and detected by Western blotting using anti-heat shock protein (HSP)72 and anti-heat shock cognate protein (HSC)73 antibodies. HSC73 was overexpressed with the pcDNA3.1 vector. Short hairpin (sh)RNA was used to downregulate HSC73 and HSP72.
Results: The activity of heat-inactivated DNA-PK recovered to about 50% of control during an additional incubation at 37?°C after heat treatment at 44?°C for 15?min in the presence of cycloheximide (which inhibits de novo protein synthesis). Maximal recovery was observed within 3?h of incubation at 37?°C after heat treatment. Constitutively expressed HSC73, which folds newly synthesized proteins, reached maximal levels 3?h after heat treatment using a co-immunoprecipitation assay with the Ku80 protein. Inhibiting HSC73, but not HSP72, expression with shRNA decreased the recovery of DNA-PK activity after heat treatment.
Conclusions: These results suggest that de novo protein synthesis is unnecessary for recovery of some heat-inactivated DNA-PK. Rather, it might be reactivated by the molecular chaperone activity of HSC73, but not HSP72. 相似文献
2. Firstly, cell viability and biochemical indicators were determined and the cell morphology was observed to confirm the cell injury and develop a cell hepatotoxicity model. Then, with the help of cell metabolomics based on UPLC-MS, the Genkwa Flos group samples were completely separated from the blank group samples in the score plots and seven upregulated as well as two down-regulated putative biomarkers in the loading plot were identified and confirmed. Besides, two signal molecules and four enzymes involved in biosynthesis pathway of lysophosphatidylcholine and the sphingosine kinase/sphingosine-1-phosphate pathway were determined to investigate the relationship between Genkwa Flos hepatotoxicity and these two classic pathways. Finally, the metabolic pathways related to specific biomarkers and two classic metabolic pathways were analyzed to explain the possible mechanism of Genkwa Flos hepatotoxicity.
3. Based on the results, lipid peroxidation and oxidative stress, phospholipase A2/lysophosphatidylcholine pathway, the disturbance of sphingosine-1-phosphate metabolic profile centered on sphingosine kinase/sphingosine-1-phosphate pathway and fatty acid metabolism might be critical participators in the progression of liver injury induced by Genkwa Flos. 相似文献
Areas covered: the principal pharmacogenetic and non-genetic differences in the pharmacology of tamoxifen and endoxifen are evaluated. To this end, references from PubMed, Embase or Web of Science, among others, were reviewed As non-genetic factors, important differences and similarities such age, or adherence to tamoxifen therapy are comprehensively illustrated. Additionally, since CYP2D6 genotypes are considered the main limitation of tamoxifen, many studies have investigated the association between the worsened clinical outcomes in patients with non-functional CYP2D6 genotypes. In this review, an overview of the research on this field is presented. Also, a summary describing the literature about individualizing tamoxifen therapy with endoxifen concentrations and its limitations is listed.
Expert opinion: z-endoxifen hydrochloride is only investigated in the metastatic setting, still more research is required before its place in therapeutics is known. Similarly, monitoring tamoxifen efficacy based on endoxifen concentrations might not be overall recommended due to the limited evidence available. 相似文献